Liposomes as fatty acids carriers in isolated rat liver: effect on energy metabolism and on isolated mitochondria activity.
The effects of fatty acids (FA)-carrier, egg-lecithin liposomes (LIPO) as alternative to BSA, on ATP, glycogen and glucose contents in isolated perfused liver of fed rats were non-invasively studied using 31P/13C nuclear magnetic resonance (NMR). Oxidative phosphorylation was studied in isolated mitochondria from the same liver consecutively to the NMR experiments. ATP content decreased slowly and ATP turnover was similar during the perfusion with saline solution (KHB) or LIPO. However, LIPO induced an enhancement of respiratory control ratio in isolated mitochondria. Tissue glycogen and glucose content decreased when FA (linoleate or linolenate) were perfused with defatted BSA (3%) or LIPO (600 mg/l) whereas glucose excretion level was unchanged and lactate excretion tended to increase, reflecting changes in the cytosolic redox state and/or an enhancement of glycolysis. Addition of FA (0.5 or 1.5 mM) to LIPO caused a dramatic fall in liver ATP, a mitochondrial uncoupling and an impairment of the phosphorylation activity. Perfusion with FA (1.5 mM) carried by BSA significantly increased the ATP degradation without change of mitochondrial function. Owing to the higher affinity of BSA than LIPO for FA, these latter could be more easily released from complex LIPO-FA, increasing their uncoupling effect. Hence, the FA concentrations have to be largely decreased from the above currently used concentrations to avoid this effect. It will then be possible to minimize the effector action of FA and to study their more specific metabolic function as fuel. It was concluded that LIPO were appropriate carriers to study the different metabolic effects of FA.
Delmas-Beauvieux
M C
MC
Service de Nutrition et Diabétologie, Hôpital Haut-Lévêque, Pessac, France. mcdb@rmsb.u-bordeaux2.fr
Leducq
N
N
Thiaudière
E
E
Diolez
P
P
Gin
H
H
Canioni
P
P
Gallis
J L
JL
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D004337:Drug Carriers; D004734:Energy Metabolism / Q000187:drug effects; D005230:Fatty Acids, Nonesterified / Q000008:administration & dosage / Q000494:pharmacology*; D066298:In Vitro Techniques; D019787:Linoleic Acid / Q000008:administration & dosage / Q000494:pharmacology; D008081:Liposomes; D008099:Liver / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D010713:Phosphatidylcholines; D051381:Rats; D017208:Rats, Wistar; D012710:Serum Albumin, Bovine; D017962:alpha-Linolenic Acid / Q000008:administration & dosage / Q000494:pharmacology
D004337:Drug Carriers; D005230:Fatty Acids, Nonesterified; D008081:Liposomes; D010713:Phosphatidylcholines; D017962:alpha-Linolenic Acid; D012710:Serum Albumin, Bovine; D000255:Adenosine Triphosphate; D019787:Linoleic Acid